The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association between rigors and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients treated with high-dose interleukin-2 (HD IL-2).
Julia Anne Batten
No relevant relationships to disclose
Wolfram E. Samlowski
No relevant relationships to disclose
Kinjal Parikh
No relevant relationships to disclose
Arun Sendilnathan
No relevant relationships to disclose
Hilda Crispin
No relevant relationships to disclose
Joan Van Atta
No relevant relationships to disclose
Daniel Sageser
No relevant relationships to disclose
Kenneth F. Grossmann
No relevant relationships to disclose
Junfeng Wang
No relevant relationships to disclose
Srinivas Kiran Tantravahi
No relevant relationships to disclose
David D. Stenehjem
No relevant relationships to disclose
Neeraj Agarwal
No relevant relationships to disclose